Esperion Therapeutics, Daiichi Sankyo Europe Reach $125M Payment Agreement Over Commercial Litigation

By Sabela Ojea Esperion Therapeutics and Daiichi Sankyo Europe GmbH said they have settled their pending commercial litigation and agreed on a $125 million...

Related Keywords

Japan ,Japanese ,Sheldon Koenig ,Sabela Ojea ,Daiichi Sankyo ,Daiichi Sankyo Europe Gmb ,Exchange Commission ,European Medicines Agency ,Daiichi Sankyo Europe Gmbh ,European Medicines ,Chief Executive Sheldon Koenig ,Sankyo Europe Gmbh ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Healthcare Life Sciences ,Biopharmaceuticals ,Corporate Industrial News ,Synd ,4568 To ,Jp 4568 ,Esperion Therapeutics ,Sespr ,Us29664w1053 ,Dsnky ,Us23381d1028 ,Jp3475350009 ,Corporate ,Industrial News ,Healthcare ,Life Sciences ,